Table 1 Patient characteristic of the overall cohort (n = 128) and after stratification for presence of MVO

Age, years

58 ± 10

57 ± 10

58 ± 10

0.925

Female, n (%)

12 (9)

8 (14)

4 (6)

0.223

Body mass index, kg/m²

26 (25–30)

27 (26–29)

26 (24–30)

0.522

Family history for AMI, n (%)

34 (27)

19 (32)

15 (22)

0.229

Current smokers, n (%)

63 (49)

28 (48)

35 (51)

0.727

RR_sys, mmHg

125 ± 24

126 ± 23

123 ± 24

0.491

RR_dia, mmHg

77 ± 15

78 ± 14

76 ± 15

0.309

Leucocyte count admission, G/l

11.7 (8.8–14.5)

11.5 (8.5–14.5)

12.0 (9.0–14.6)

0.649

Leucocyte count max, G/l

12.7 (10.8–15.8)

11.9 (10.3–15.2)

13.1 (11.7–16.4)

0.061

Total cholesterol, mg/dl

192 ± 44

185 ± 41

198 ± 47

0.108

Low-density lipoprotein, mg/dl

128 ± 42

123 ± 39

132 ± 44

0.230

High-density lipoprotein, mg/dl

42 (36–49)

40 (33–53)

43 (38–49)

0.320

Triglycerides, mg/dl

102 (78–151)

108 (80–163)

96 (77–142)

0.276

Plasma glucose admission, mg/dl

135 (115–161)

134 (116–163)

137 (112–160)

0.728

HbA1c, %

5.6 (5.4–6.0)

5.6 (5.4–6.1)

5.6 (5.3–5.9)

0.792

Creatinine admission, mg/dl

0.93 (0.82–1.05)

0.92 (0.76–1.07)

0.93 (0.83–1.04)

0.877

Creatinine max, mg/dl

1.04 (0.92–1.15)

1.03 (0.91–1.13)

1.06 (0.96–1.20)

0.261

hs-cTnT admission, ng/l

226 (29–2168)

201 (18–1388)

523 (34–4001)

0.036

hs-cTnT max, ng/l

5254 (2169–8735)

2866 (1026–5524)

6985 (4193–13639)

<0.001

CK admission, U/l

353 (174–1182)

301 (148–862)

435 (207–2433)

0.048

CK max, U/l

2111 (1168–3674)

1228 (625–2323)

2776 (1749–4686)

<0.001

NT-proBNP admission, ng/l

139 (66–511)

128 (66–360)

159 (71–687)

0.487

NT-proBNP max, ng/l

717 (184–1700)

360 (131–924)

1084 (312–2649)

0.003

hs-CRP admission, mg/dl

0.23 (0.11–0.61)

0.34 (0.15–0.66)

0.19 (0.09–0.56)

0.119

hs-CRP max, mg/dl

2.20 (0.96–4.56)

1.53 (0.64 3.02)

2.84 (1.68–7.44)

<0.001

LDH admission, U/l

238 (196–364)

222 (182–301)

257 (207–493)

0.009

LDH max, U/l

593 (354–882)

358 (271–624)

742 (534–1182)

<0.001

AST admission, U/l

82 (34–210)

57 (31–113)

126 (40–306)

0.008

AST max, U/l

239 (128–423)

151 (75–256)

340 (213–547)

<0.001

ALT admission, U/l

37 (27–58)

31 (25–46)

45 (32–75)

0.003

ALT max, U/l

60 (42–87)

47 (32–69)

71 (52–111)

<0.001

γGT admission, U/l

37 (25–52)

36 (26–50)

39 (23–59)

0.857

γGT max, U/l

40 (26–63)

37 (26–51)

41 (26–71)

0.482

AP admission, U/l

64 (53–79)

64 (52–80)

63 (54–76)

0.918

AP max, U/l

64 (53–81)

64 (52–83)

64 (54–81)

0.951

Total bilirubin admission, mg/dl

0.49 (0.38–0.69)

0.44 (0.37–0.65)

0.52 (0.40–0.73)

0.160

Total bilirubin max, mg/dl

0.62 (0.43–0.84)

0.60 (0.42–0.84)

0.62 (0.45–0.85)

0.668